Samenvatting
Gedurende jaren was er weinig of geen belangstelling voor de slaap, noch vanuit de geneeskunde, noch vanuit de psychologie. Merkwaardig, want iemand die 60 jaar is heeft daarvan zo’n 20 jaar geslapen. Tot de leeftijd van drie jaar ongeveer heeft een kind meer tijd in slaap- dan in waaktoestand doorgebracht. Indien dit fenomeen, dat we bij vrijwel alle organismen kunnen observeren, geen belangrijke vitale zou functie hebben, zou dat een opmerkelijke vergissing in de evolutie zijn (McNamara,
Literatuur
American Academy of Sleep Medicine (2005). International classification of sleep disorders, 2nd ed.: diagnostic and coding manual. American Academy of Sleep Medicine, Westchester, il.
Ancoli-Israel, S. (2005). Long-term use of sedative hypnotics in older patients with insomnia. Sleep Medicine, 6, 107–113.
American Psychiatric Association.(2000). Diagnostic and statistical manual of mental disorders (4th ed., revised), Washington.
Arendt, J. & Skene, D.J.(2005). Melatonin as a chronobiotic. Sleep Medicine Reviews, 9, 25-39.
Aserinsky, E. & Kleitman, N. (1953). Regularly occurring periods of eye motility, and concomitant phenomena, during sleep. Science, 118, 273–274.
Aston-Jones, G., Meijas-Aponte, C.A. & Waterhouse, B. (2009). Norepinephrine: cns Pathways and Neurophysiology. In: Larry R. Squire (Ed.), Encyclopedia of Neuroscience, Academic Press, Oxford, 1237-1248.
Banks, S.& Dinges, D.F. (2007). Behavioral and physiological consequences of sleep restriction. Journal of Clinical Sleep Medicine, 3, 519–528.
Barkoukis, T.J. & Avidan, A.Y. (2007). Review of Sleep Medicine. Elsevier Health Sciences.
Basheer, R., McKenna, J.T. & McCarley, R.W. (2009). Pharmacology of Sleep: Adenosine, In: Larry R. Squire (Ed), Encyclopedia of Neuroscience, Academic Press, Oxford, 601-610.
Benca, R. (2004). Special considerations in insomnia diagnosis and management: depressed, elderly, and chronic pain populations. Journal of Clinical Psychiatry, 65, S26–S35.
Bonnet, M.H. & Arand, D.L. (1997). Hyperarousal and insomnia. Sleep Medicine Reviews, 1,2, 97-108.
Bonnet, M.H. & Arand, D.L.(2003). Situational insomnia: consistency, predictors, and outcomes. Sleep, 26,8, 1029-1036.
Borbely, A. & Achermann, P.(2005). Sleep Homeostasis and Models of Sleep Regulation. In: Meir H. Kryger, Thomas Roth, William C. Dement, (Eds.) Principles and Practice of Sleep Medicine. (4e dr.) Philadelphia: W.B. Saunders, 405-417.
Brzezinski, A., Vangel, M.G., Wurtman, R.J., Norrie, G., Zhdanova, I., Ben-Shushan, A. & Ford, I. (2005). Effects of exogenous melatonin on sleep: a meta-analysis. Sleep Medicine Reviews, 9,1, 41-50.
Carskadon, M.A. & Rechtschaffen, A.(2005). Monitoring and staging human sleep. In: Meir H. Kryger, Thomas Roth, William C. Dement, (Eds.). Principles and practice of sleep medicine. (4e dr.) Philadelphia: Elsevier, 1359–1377.
Cirelli, C. & Tononi, G. (2008). Is Sleep Essential? PLoS Biology, 6, 8, 1605-1611.
Cluydts, R. (2003). Comparing the effects of sleep loss after experimental sleep deprivation and in clinical patients. Sleep Medicine Reviews, 7,4, 293-295.
Czeisler, C., Buxton, O.M. & Khalsa, S.B.S. (2005). The Human Circadian Timing System and Sleep-Wake Regulation, In: Meir H. Kryger, Thomas Roth, William C. Dement, (Eds.), Principles and Practice of Sleep Medicine. (4e dr.). Philadelphia: W.B. Saunders, 375-394.
Dijk, D.J. & Archer, S.N. (2009). period3, circadian phenotypes, and sleep homeostasis. Sleep Medicine Reviews, doi.
Edinger, J.D., Bonnet, M.H., Bootzin, R.R., Doghramji, K., Dorsey, C.M., Espie, C.A., Jamieson, A.O., McCall, V.W., Morin, C.M. & Stepanski, E.J. (2004). Derivation of research diagnostic criteria for insomnia: Report of an American Academy of Sleep Medicine Work Group. Sleep, 27, 1567–1596.
Edinger, J.D. & Fins, A.I. (1995) The distribution and clinical significance of sleep time misperceptions among insomniacs. Sleep, 18,4, 232-239.
Edinger, J.D. & Krystal, A.D. (2003). Subtyping primary insomnia: is sleep state misperception a distinct clinical entity? Sleep Medicine Reviews, 7,3, 203-214.
Espie, C.A., Broomfield, N.M., MacMahon, K.M.A., Macphee, L.M. & Taylor, L.M. (2006). The attention-intention-effort pathway in the development of psychophysiologic insomnia: A theoretical review. Sleep Medicine Reviews, 10,4, 215-245.
Fort, P., Bassetti, C.L. & Luppi, P.H. (2009). Alternating vigilance states: new insights regarding neuronal networks and mechanisms. European Journal of Neuroscience, 29,9, 1741 – 1753.
Franken, P. & Dijk, D.J. (2009). Circadian clock genes and sleep homeostasis. European Journal of Neuroscience, 29,9, 1820-1829.
Franzen, P.L. & Buysse, D.J. (2008). Sleep disturbances and depression: risk relationships for subsequent depression and therapeutic implications. Dialogues Clinical Neuroscience, 10,4, 473-481.
Fuller, P.M., Saper, C.B. & Lu, J. (2007). The pontine rem switch: past and present. Journal of Physiology, 584,3, 735-741.
Glass, J., Lanctôt, K.L., Herrmann, N., Sproule, B.A. & Busto, U.E. (2005). Sedative hypnotics in older people with insomnia: meta-analysis of risks and benefits. British Medical Journal, 331, 1169.
Haas, H.L., Selbach, O. & Sergeeva, O.A. (2009). Sleep and Sleep States: Histamine Role, In: Larry R. Squire (Ed.), Encyclopedia of Neuroscience. Oxford: Academic Press, 919-928.
Hajak, G.(2002). ‘As needed’ pharmacotherapy Regular with stimulus control treatment in chronic insomnia-assessment of a novel intervention strategy in a primary care setting. Annals of Clinical Psychiatry, 14, 1–7.
Harvey, A. (2002). A cognitive model of insomnia. Behavioral Research Therapy, 40, 869–893.
Heijden, K.B. van der, Smits, M.G., Someren, E.J. van & Gunning, W.B. (2005). Idiopathic chronic sleep onset insomnia in attention-deficit/hyperactivity disorder: a circadian rhythm sleep disorder. Chronobiology International, 22,3, 559-570.
Iber, C., Ancoli-Israel, S., Chesson, A. & Quan, S.F. (2007) The aasm manual for the scoring of sleep and associated events: rules, terminology, and technical specification. ; Westchester, il: American Academy of Sleep Medicine.
Irwin, M., Clark, C., Kennedy, B., Gillin, J.C. & Ziegler, M. (2003). Nocturnal catecholamines and immune function in insomniacs, depressed patients, and control subjects. Brain, Behavior, and Immunity, 17,5, 365-372.
Jacobs, G.D., Pace-Schott, E.F., Stickgold, R. & Otto, M.W. (2004). Cognitive Behavior Therapy and Pharmacotherapy for Insomnia: A Randomized Controlled Trial and Direct Comparison. Archives of Internal Medicine,164, 1888-1896.
Jenni, O.G., LeBourgeois, M.K. (2006). Understanding sleep-wake behavior and sleep disorders in children: the value of a model. Current Opinions in Psychiatry,19,3, 282-287.
Jones, B.E. (2009). Sleep-Wake State Regulation by Acetylcholine, In: Larry R. Squire (Ed), Encyclopedia of Neuroscience. Oxford: Academic Press, 1075-1078.
Kerkhofs, M. & Lavie, P. (2000). Historical note: Frederic Bremer 1892-1982: a pioneer in sleep research. Sleep Medicine Reviews, 4,5, 505-514.
Krueger, J.M., Rector, D.M. & Churchill, L. (2007). Sleep and Cytokines, Sleep Medicine Clinics, 2,2, 161-169.
Krystal, A.D. & Walsh, J.W. (2003). Sustained efficacy of eszopiclone over 6 months of nightly treatment: results of a randomized, double-blind, placebo-controlled study in adults with chronic insomnia. Sleep, 26, 793–799.
Kushida, C.A. (2008). Handbook of Sleep Disorders. (2e dr.) New York: Informa Health Care.
Lichstein, K.L., Durrence, H.H., Taylor, D.J., Bush, A.J. & Riedel, B.W. (2002). Quantitative criteria for insomnia. Behavior Research and Therapy, 41, 427–445.
Lichstein, K.L., Stone, K.C., Nau, S.D., McCrae, C.S. & Payne, K.L. (2006) Insomnia in the Elderly. Sleep Medicine Clinics, 1,2, 221-229.
Lu, J., Sherman, D., Devor, M. & Saper, C.B. (2006). A putative flip-flop switch for control of rem sleep. Nature, 441, 7093, 589-594.
Manber, R., Edinger, J.D., Gress, J.L., San Pedro-Salcedo, M.G., Kuo, T.F. & Kalista, T. (2008). Cognitive behavioral therapy for insomnia enhances depression outcome in patients with comorbid major depressive disorder and insomnia. Sleep, 31,4, 447-448.
McCarley, R.W. (2007). Neurobiology of rem and nrem sleep. Sleep Medicine, 8,4, 302-330.
McNamara, P. (2009). Evolution of Sleep Phylogenetic and Functional Perspectives. Cambridge
Meerlo, P., Sgoifo, A., De Boer, S.F. & Koolhaas, J.M. (1999). Long-lasting consequences of a social conflict in rats: behavior during the interaction predicts subsequent changes in daily rhythms of heart rate, temperature, and activity. Behavioral Neuroscience,113,6, 1283-1290.
Mignot, E. (2008). Why we sleep: the temporal organization of recovery. PLoS Biology, 6,4, 661-669.
Monti, J.M. & Jantos, H. (2008). The roles of dopamine and serotonin, and of their receptors, in regulating sleep and waking. In: Giuseppe Di Giovann, Vincenzo Di Matteo and Ennio Esposito (Eds.), Progress in Brain Research. Elsevier, 625-646.
Morin, C.M. (2006).Psychological and behavioral treatment of insomnia: update of the recent evidence (1998–2004). Sleep, 29, 1398–414.
Morin, C.M. & Espie, C.A. (2003). Insomnia. A clinician’s guide to assessment and treatment. Springer.
Morin, C.M., Rodrigue, S. & Ivers, H. (2003). Role of stress, arousal, and coping skills in primary insomnia. Psychosomatic Medicine, 65,2, 259-267.
Moruzzi, G. & Magoun, H.W. (1949). Brain stem reticular formation and activation of the eeg. Electroencephalography and Clinical Neurology, 1, 455-73.
Moser, D., Anderer, P., Gruber, G., Parapatics, S., Loretz, E., Boeck, M., Kloesch, G., Heller, E., Schmidt, A., Danker-Hopfe, H., Saletu, B., Zeitlhofer, J. & Dorffner, G. (2009). Sleep classification according to aasm and Rechtschaffen & Kales: effects on sleep scoring parameters. Sleep, 32,2, 139-149.
Murillo-Rodríguez, E., Arias-Carrión, O., Sanguino-Rodríguez, K., González-Arias, M. & Haro, R. (2009). Mechanisms of sleep-wake cycle modulation. cns Neurol Disord Drug Targets, 8,4, 245-253.
National Institutes of Health. (2005). National Institutes of Health State of the Science Conference statement on Manifestations and Management of Chronic Insomnia in Adults. Sleep,28, 1049–1057.
Nierenberg, A.A., Husain, M.M., Trivedi, M.H., Fava, M., Warden, D., Wisniewski, S.R., Miyahara, S. & Rush, A.J. (2009). Residual symptoms after remission of major depressive disorder with citalopram and risk of relapse: a star*d report. Psychological Medicine, 22, 1-10.
Nishino, S. (2007). The hypothalamic peptidergic system, hypocretin/orexin and vigilance control. Neuropeptides, 41,3, 117-133.
Nofzinger, E.A., Buysse, D.J., Germain, A., Price, J.C., Miewald, J.M. & Kupfer, D.J. (2004). Functional neuroimaging evidence for hyperarousal in insomnia. American Journal Psychiatry, 161,11, 2126-2128.
Nofzinger, E.A.(2008). Functional neuroimaging of sleep disorders. Current Pharmaceutical Design, 14,32, 3417-3429.
Pandi-Perumal, S.R., Zisapel, N., Srinivasan, V. & Cardinali, D.P. (2005). Melatonin and sleep in aging population. Experimental Gerontology, 40,12, 911-925.
Parry, B.L., Martinez, L.F., Maurer, E.L., Lopez, A.M., Sorenson, D. & Meliska, C.J. (2006). Sleep, rhythms and women’s mood. Part II. Menopause. Sleep Medicine Reviews, 10,3, 197-208.
Pavlova, M., Berg, O., Gleason, R., Walker, F., Roberts, S. & Regestein, Q. (2001). Self-reported hyperarousal traits among insomnia patients. Journal of Psychosomatic Research, 51,2, 435-441.
Perlis, M.L. (1997). Psychophysiological insomnia: the behavioural model and a neurocognitive perspective. Journal of Sleep Research, 6, 179–188.
Perlis, M.L., Smith, L.J., Lyness, J.M., Matteson, S.R., Pigeon, W.R., Jungquist, C.R. & Tu, X. (2006). Insomnia as a risk factor for onset of depression in the elderly. Behavioral Sleep Medicine, 4,2, 104-113.
Peyron, C., Sapin, E., Leger, L., Luppi, P.H. & Fort, P. (2009). Role of the melanin-concentrating hormone neuropeptide in sleep regulation. Peptides, doi.
Rechtschaffen, A. & Kales, A. (1968). A manual of standardized terminology, techniques and scoring system of sleep stages in human subjects. Brain Information Service/Brain Research Institute, University of California, Los Angeles.
Riemann, D. (2007). Insomnia and comorbid psychiatric disorders. Sleep Medicine, 8,4, 15-20.
Robertson, J.A., Broomfield, N.M. & Espie, C.A. (2007). Prospective comparison of subjective arousal during the pre-sleep period in primary sleep-onset insomnia and normal sleepers. Journal of Sleep Research, 16,2, 230-238.
Rosenwasser, M. (2009). Functional neuroanatomy of sleep and circadian rhythms. Brain Research Reviews, doi.
Roth, T. (2005). An evaluation of the efficacy and safety of eszopiclone over 12 months in patients with chronic primary insomnia. Sleep Medicine, 6, 487–495.
Salin-Pascual, R.J., Roehrs, T.A., Merlotti, L.A., Zorick, F. & Roth, T. (1992). Long-term study of the sleep of insomnia patients with sleep state misperception and other insomnia patients. American Journal of Psychiatry, 149,7, 904-908.
Saper, C.B., Chou, T.C. & Scammell, T.E. (2001). The sleep switch: hypothalamic control of sleep and wakefulness. Trends in Neurosciences, 24,12, 726-731.
Saper, C.B. (2006). Staying awake for dinner: hypothalamic integration of sleep, feeding, and circadian rhythms. Progress in Brain Research, 153, 243-252.
Saper, C.B. (2005). Hypothalamic Regulation of Sleep and Circadian Rhythms. Nature, 437, 1257-1263.
Sateia, M.J., Doghramji, K., Hauri, P.J. & Morin, C.M. (2000). Evaluation of chronic insomnia. Sleep, 23, 243–308.
Schulz, P. & Steimer, T. (2009). Neurobiology of circadian systems. cns Drugs,23, 2, 3-13.
Someren, E.J. van (2007). Melatonin treatment efficacy: For whom and for what? Sleep Medicine, 8,3, 193-195.
Spielman, A.J. & Glovinsky, P. (1991). The varied nature of insomnia. In P.J. Hauri (Ed.). Case studies in insomnia. New York, Plenum Press.
Steiger, A. (2006). Peptides and Sleep. In: Abba J. Kastin (Ed.), Handbook of Biologically Active Peptides. Burlington: Academic Press, 1521-1528.
Stepanski, E.J. & Wyatt, J.K. (2003). Use of sleep hygiene in the treatment of insomnia. Sleep Medicine Reviews, 7,3, 215-225.
Taylor, D.J. & Mallory, L.J.. (2007). Comorbidity of chronic insomnia with medical problems. Sleep, 30, 213–218.
Taylor, D.J., Lichstein, K.L., Durrence, H.H., Reidel, B.W. & Bush, A.J. (2005). Epidemiology of insomnia, depression, and anxiety. Sleep, 28,11, 1457-1464.
Todd Arnedt, J. (2006). Evaluation of insomnia patients. Sleep Medicine Clinics, 1, 319–332.
Troy Curry, D., Eisenstein, R.D. & Walsh, J.K. (2006). Pharmacologic Management of Insomnia: Past, Present, and Future. Psychiatric Clinics of North America, 29,4, 871-893.
Vogel, G.W., Vogel, F., McAbee, R.S. & Thurmond, A.J. (1980). Improvement of depression by rem sleep deprivation. New findings and a theory. Archives of General Psychiatry, 37,3, 247-253.
Walsh, J.K., Roehrs, T. & Roth, T. (2005). Pharmacologic Treatment of Primary Insomnia. In: Principles and Practice of Sleep Medicine (4e dr.), 749-760.
World Health Organization (1993). The icd-10 Classification of Mental and Behavioural Disorders, Diagnostic Criteria for Research. Geneva: World Health Organization.
Wilson, S. & Nutt, D. (2007). Treatment of insomnia. Psychiatry, 6,7, 301-304.
Author information
Authors and Affiliations
Additional information
Prof.dr. R. Cluydts, biologisch psycholoog, hoogleraar Biologische Psychologie, Vrije Universiteit Brussel, rcluydts@vub.ac.be; dr. E. van Someren, neurobioloog, hoofd van de afdeling Slaap en Cognitie, Nederlands Instituut voor Neurowetenschappen, Amsterdam
Rights and permissions
About this article
Cite this article
Cluydts, R., van Someren, E. Slaap en slaapstoornissen. NEPR 13, 153–167 (2009). https://doi.org/10.1007/BF03080172
Issue Date:
DOI: https://doi.org/10.1007/BF03080172